Page 107 - CIBEREHD2016-ENG

Most relevant scientific articles
• Trivedi P.J., Corpechot C., Pares A., Hirschfield G.M. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists. Hepatology. 2016;63(2):644-659.
• Nevens F., Andreone P., Mazzella G., Strasser S.I., Bowlus C., Invernizzi P. et al. A Placebo- controlled trial of obeticholic acid in primary biliary cholangitis. New England Journal of Medicine. 2016;375(7):631-643.
• Bolier R, Tolenaars D, Kremer AE, Saris J, Parés A, Verheij J et al. Enteroendocrine cells are a potential source of serum autotaxin in men.Biochimica et biophysica acta. 2016;.
• Guañabens N, Mumm S, Gifre L, Ruiz-Gaspà S, Demertzis JL, Stolina M et al. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman with Systemic Lupus Erythematosus.Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2016;.
• Guañabens N, Ruiz-Gaspà S, Gifre L, Miquel R, Peris P, Monegal A et al. Sclerostin Expression in Bile Ducts of Patients with Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2016.
Hightlights
Participation in a project of excellence funded by Carlos III Health Institute aimed at building a framework for the design of nanomedicines based on major histocompatibility complex peptides (pMHC) for different autoimmune diseases including primary biliary cholangitis, to demonstrate that they can be used in humanized mice for the selection of pMHC-based cells with nanomedicines for future clinical trials, and to identify patients who most likely would to respond to this therapy.
The Spanish registry of cholestatic and autoimmune hepatic diseases (ColHai) has been established within the Spanish Association for the Study of the Liver (AEEH) in collaboration with CIBEREHD.
Members of the research group have participated in the international networks of primary biliary cholangitis (Global-PBC), primary sclerosing cholangitis (IPSCSG) and the international group of autoimmune hepatitis, which has established a worldwide AIH registry. Dr. Parés is also a member of the steering committee of the European Reference Network on Rare Hepatological Diseases (RARE-LIVER) approved by the Committee of Member States for European Reference Networks (ERN).
Dr. Nuria Guañabens has been awarded with the Steven Boonen Research Award by the European Calcified Tissue Societey (ECTS) during the annual meeting held in Rome (Italy).
EHD
research Groups 107